Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H11ClN4 |
Molecular Weight | 294.738 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC2=C(C=C1)N3C=NN=C3CN=C2C4=CC=CC=C4
InChI
InChIKey=CDCHDCWJMGXXRH-UHFFFAOYSA-N
InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2
Molecular Formula | C16H11ClN4 |
Molecular Weight | 294.738 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:23:27 UTC 2023
by
admin
on
Fri Dec 15 15:23:27 UTC 2023
|
Record UNII |
36S3EQV54C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1012
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
||
|
WHO-ATC |
N05CD04
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
||
|
NDF-RT |
N0000007542
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
||
|
LIVERTOX |
NBK548660
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
||
|
WHO-VATC |
QN05CD04
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
||
|
NDF-RT |
N0000175694
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
||
|
DEA NO. |
2756
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C47520
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
D004949
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
CC-24
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
3261
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
36S3EQV54C
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
SUB07241MIG
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
1056
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
1249905
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
7550
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
4077
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | RxNorm | ||
|
Estazolam
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
DB01215
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
100000082361
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
ESTAZOLAM
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
CHEMBL285674
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
36S3EQV54C
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
3611
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
249-982-4
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
m5027
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID5020572
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
290818
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
4858
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY | |||
|
29975-16-4
Created by
admin on Fri Dec 15 15:23:28 UTC 2023 , Edited by admin on Fri Dec 15 15:23:28 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT |
m. 1-0x0-estazolam was about five times less effective than the parent drug
in terms of brain concn. necessary to disrupt rota-rod performance but only twice in
respect to the anticonvulsant activity.
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |